TY - JOUR
T1 - Primary biliary cirrhosis
T2 - Dutch application of the Mayo Model before and after orthotopic liver transplantation
AU - Van Dam, Gooitzen M.
AU - Verbaan, Bart W.
AU - Therneau, Terry M.
AU - Dickson, E. Rolland
AU - Malinchoc, Michael
AU - Murtaugh, Paul A.
AU - Huizenga, Johannus R.
AU - Gips, Chris H.
PY - 1997/7/17
Y1 - 1997/7/17
N2 - Background/Aims: A retrospective study of primary biliary cirrhosis (PBC) was performed to study the Original Mayo Model for predicting survival by a Dutch data-set of patients, presentation of disease progression assessment of liver transplantation, prediction of post-transplantation survival; and the addition of two laboratory variables to the Original Mayo Model. Materials and Methods: Survival of 83 patients, 37 of whom underwent transplantation, were studied. Mean follow-up was 6.0 ± 0.45 SEM years. Risk score at diagnosis, platelet count, and serum sodium were analyzed in a Cox model. Results: The Original Mayo Model estimated survival for low-, medium-, and high-risk groups accurately and it also presented disease progression. Baseline Mayo risk score in a Cox model had a regression coefficient of 1.01, indicating an excellent predictor p < 0.0001. Platelet count was a predictor of survival (p < 0.002) whereas serum sodium did not (p = 0.67). A new model combined of the Original Mayo risk score and platelet count predicted survival in high-risk patients somewhat better compared to the Original Mayo Model. With both models, liver transplantation had a significant beneficial effect on survival (p < 0.001). The scores revealed no significant influence (p = 0.47) for overall post-transplantation survival. Conclusions: The Original Mayo Model remains the model of choice for patients with PBC for prognostication, from 3-8 years, is a useful tool in the assessment of liver transplantation but not an indicator of post-transplantation survival. Platelet count showed to have additional prognostic value. A new model combined of platelet count and the Original Mayo risk score did predict survival in high-risk groups slightly better compared to the Original Mayo Model.
AB - Background/Aims: A retrospective study of primary biliary cirrhosis (PBC) was performed to study the Original Mayo Model for predicting survival by a Dutch data-set of patients, presentation of disease progression assessment of liver transplantation, prediction of post-transplantation survival; and the addition of two laboratory variables to the Original Mayo Model. Materials and Methods: Survival of 83 patients, 37 of whom underwent transplantation, were studied. Mean follow-up was 6.0 ± 0.45 SEM years. Risk score at diagnosis, platelet count, and serum sodium were analyzed in a Cox model. Results: The Original Mayo Model estimated survival for low-, medium-, and high-risk groups accurately and it also presented disease progression. Baseline Mayo risk score in a Cox model had a regression coefficient of 1.01, indicating an excellent predictor p < 0.0001. Platelet count was a predictor of survival (p < 0.002) whereas serum sodium did not (p = 0.67). A new model combined of the Original Mayo risk score and platelet count predicted survival in high-risk patients somewhat better compared to the Original Mayo Model. With both models, liver transplantation had a significant beneficial effect on survival (p < 0.001). The scores revealed no significant influence (p = 0.47) for overall post-transplantation survival. Conclusions: The Original Mayo Model remains the model of choice for patients with PBC for prognostication, from 3-8 years, is a useful tool in the assessment of liver transplantation but not an indicator of post-transplantation survival. Platelet count showed to have additional prognostic value. A new model combined of platelet count and the Original Mayo risk score did predict survival in high-risk groups slightly better compared to the Original Mayo Model.
KW - Disease progression
KW - Original Mayo Model
KW - Platelet count
KW - Primary Biliary Cirrhosis
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=0030997480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030997480&partnerID=8YFLogxK
M3 - Article
C2 - 9222682
AN - SCOPUS:0030997480
SN - 0172-6390
VL - 44
SP - 732
EP - 743
JO - Hepato-Gastroenterology
JF - Hepato-Gastroenterology
IS - 15
ER -